Cargando…
Therapeutic Potency of PI3K Pharmacological Inhibitors of Gastrointestinal Cancer
Therapeutic targeting of phosphatidyl-inositol 3-kinase (PI3K) is considered as a possible strategy in several types of cancer, including gastrointestinal ones. In vitro and in vivo studies indicated the significance of proapoptotic and antiproliferative inhibition of PI3K. Although there are many p...
Autores principales: | Hashemzadeh, Kamelia, Jokar, Mohammad Hassan, Sedighi, Sima, Moradzadeh, Maliheh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488499/ https://www.ncbi.nlm.nih.gov/pubmed/31049177 http://dx.doi.org/10.15171/mejdd.2018.122 |
Ejemplares similares
-
A comparative study of anti-leukemic effects of kaempferol and epigallocatechin-3-gallate (EGCG) on human leukemia HL-60 cells
por: Jokar, Mohammad Hassan, et al.
Publicado: (2021) -
Serum lysyl oxidase concentration increases in long-standing systemic sclerosis: Can lysyl oxidase change over time?
por: Jokar, Mohammad Hassan, et al.
Publicado: (2021) -
The p110δ crystal structure uncovers mechanisms for selectivity and potency of novel PI3K inhibitors
por: Berndt, Alex, et al.
Publicado: (2010) -
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013) -
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases
por: Banham-Hall, Edward, et al.
Publicado: (2012)